Kornberg, A.; Witt, U.; Kornberg, J.; MĂĽller, K.; Friess, H.; Thrum, K.
Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival. J. Clin. Med. 2020, 9, 656.
https://doi.org/10.3390/jcm9030656
AMA Style
Kornberg A, Witt U, Kornberg J, MĂĽller K, Friess H, Thrum K.
Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival. Journal of Clinical Medicine. 2020; 9(3):656.
https://doi.org/10.3390/jcm9030656
Chicago/Turabian Style
Kornberg, Arno, Ulrike Witt, Jennifer Kornberg, Katharina MĂĽller, Helmut Friess, and Katharina Thrum.
2020. "Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival" Journal of Clinical Medicine 9, no. 3: 656.
https://doi.org/10.3390/jcm9030656
APA Style
Kornberg, A., Witt, U., Kornberg, J., MĂĽller, K., Friess, H., & Thrum, K.
(2020). Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival. Journal of Clinical Medicine, 9(3), 656.
https://doi.org/10.3390/jcm9030656